Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Details

Connection

Jordan Karlitz to United States

This is a "connection" page, showing publications Jordan Karlitz has written about United States.

 
Connection Strength
  
 
 
0.687
  
  1. Greene M, Gohil S, Stieber B, Ozbay AB, Le QA, Kakuturu R, LeMaster JW, Dore M, Fendrick AM, Anderson JC, Karlitz JJ. Utilization of colorectal cancer screening modalities in the United States (2017-2023): a national multi-payer claims database analysis. Curr Med Res Opin. 2025 Sep; 41(9):1619-1628.
    View in: PubMed
    Score: 0.066
  2. Montminy EM, Zhou M, Edelson JC, Karlitz JJ. Stage-Stratified Incidence Rates of Colorectal Adenocarcinoma Among Patients Aged 46 to 49 in the United States. JAMA Netw Open. 2024 03 04; 7(3):e241848.
    View in: PubMed
    Score: 0.059
  3. Montminy EM, Zhou M, Long C, Wani S, Patel SG, Karlitz JJ. Impact of Carcinoid and Appendiceal Site Inclusion on Early Onset Colon Cancer Incidence Rate Analysis in the United States. Clin Gastroenterol Hepatol. 2023 10; 21(11):2972-2974.e1.
    View in: PubMed
    Score: 0.054
  4. Montminy EM, Zhou M, Maniscalco L, Heda R, Kim MK, Patel SG, Wu XC, Itzkowitz SH, Karlitz JJ. Shifts in the Proportion of Distant Stage Early-Onset Colorectal Adenocarcinoma in the United States. Cancer Epidemiol Biomarkers Prev. 2022 02; 31(2):334-341.
    View in: PubMed
    Score: 0.051
  5. Montminy EM, Zhou M, Maniscalco L, Penrose H, Yen T, Patel SG, Wu XC, Karlitz JJ. Trends in the Incidence of Early-Onset Colorectal Adenocarcinoma Among Black and White US Residents Aged 40 to 49 Years, 2000-2017. JAMA Netw Open. 2021 11 01; 4(11):e2130433.
    View in: PubMed
    Score: 0.050
  6. Montminy EM, Zhou M, Maniscalco L, Abualkhair W, Kim MK, Siegel RL, Wu XC, Itzkowitz SH, Karlitz JJ. Contributions of Adenocarcinoma and Carcinoid Tumors to Early-Onset Colorectal Cancer Incidence Rates in the United States. Ann Intern Med. 2021 02; 174(2):157-166.
    View in: PubMed
    Score: 0.047
  7. Montminy EM, Jang A, Conner M, Karlitz JJ. Screening for Colorectal Cancer. Med Clin North Am. 2020 Nov; 104(6):1023-1036.
    View in: PubMed
    Score: 0.047
  8. Abualkhair WH, Zhou M, Ochoa CO, Lacayo L, Murphy C, Wu XC, Karlitz JJ. Geographic and intra-racial disparities in early-onset colorectal cancer in the SEER 18 registries of the United States. Cancer Med. 2020 12; 9(23):9150-9159.
    View in: PubMed
    Score: 0.047
  9. Abualkhair WH, Zhou M, Ahnen D, Yu Q, Wu XC, Karlitz JJ. Trends in Incidence of Early-Onset Colorectal Cancer in the United States Among Those Approaching Screening Age. JAMA Netw Open. 2020 01 03; 3(1):e1920407.
    View in: PubMed
    Score: 0.044
  10. Karlitz JJ, Oliphant AB, Greenwald DA, Pochapin MB. The American College of Gastroenterology and the 80% by 2018 Colorectal Cancer Initiative: A Multifaceted Approach to Maximize Screening Rates. Am J Gastroenterol. 2017 Sep; 112(9):1360-1362.
    View in: PubMed
    Score: 0.038
  11. Karlitz JJ, Hsieh MC, Liu Y, Blanton C, Schmidt B, Jessup JM, Wu XC, Chen VW. Population-Based Lynch Syndrome Screening by Microsatellite Instability in Patients =50: Prevalence, Testing Determinants, and Result Availability Prior to Colon Surgery. Am J Gastroenterol. 2015 Jul; 110(7):948-55.
    View in: PubMed
    Score: 0.032
  12. Gohil S, Omar M, Carnes ML, Karlitz JJ, Usry N, Idriss R, Greene M. Adherence to multi-target stool DNA colorectal cancer screening among Medicare patients in Alabama. Curr Med Res Opin. 2026 May; 42(5):941-951.
    View in: PubMed
    Score: 0.017
  13. Gohil S, Omar M, Karlitz J, Young P, Greene M. Multi-target stool DNA test adherence among individuals screened for colorectal cancer through the US Defense Health Agency. Curr Med Res Opin. 2026 Feb; 42(2):195-203.
    View in: PubMed
    Score: 0.017
  14. Greene M, Le QA, Ozbay AB, Karlitz JJ, Fendrick AM. Completing the colorectal cancer screening process: impact of eliminating cost-sharing for follow-up colonoscopy. Curr Med Res Opin. 2025 Sep; 41(9):1697-1703.
    View in: PubMed
    Score: 0.017
  15. Greene M, Pew T, Sakthisivabalan L, Zapatier J, Arroyo J, López JVR, Karlitz JJ, Duarte M. Adherence to colorectal cancer screening with multi-target stool DNA testing among first-time average-risk users in federally qualified health centers. Curr Med Res Opin. 2025 Jun; 41(6):983-993.
    View in: PubMed
    Score: 0.016
  16. Greene M, Pew T, Ozbay AB, Rincón López JV, Brooks D, Karlitz J, Duarte M. Impact of Spanish Language Outreach on Multi-Target Stool DNA Test Adherence in a Federally Qualified Health Center in the United States. Cancer Control. 2025 Jan-Dec; 32:10732748251343334.
    View in: PubMed
    Score: 0.016
  17. Yen T, Scolaro J, Montminy E, Karlitz JJ, Wani S, Patel SG. Spectrum of Advanced Colorectal Neoplasia and Anticipated Yield of Average-Risk Screening in Veterans Under Age 50. Clin Gastroenterol Hepatol. 2023 03; 21(3):827-829.e3.
    View in: PubMed
    Score: 0.013
  18. Fendrick AM, Fisher DA, Saoud L, Ozbay AB, Karlitz JJ, Limburg PJ. Impact of Patient Adherence to Stool-Based Colorectal Cancer Screening and Colonoscopy Following a Positive Test on Clinical Outcomes. Cancer Prev Res (Phila). 2021 09; 14(9):845-850.
    View in: PubMed
    Score: 0.012
  19. Fisher DA, Karlitz JJ, Jeyakumar S, Smith N, Limburg P, Lieberman D, Fendrick AM. Real-world cost-effectiveness of stool-based colorectal cancer screening in a Medicare population. J Med Econ. 2021 Jan-Dec; 24(1):654-664.
    View in: PubMed
    Score: 0.012
  20. Dwyer AJ, Murphy CC, Boland CR, Garcia R, Hampel H, Limburg P, Lowery J, Zauber AG, Waring S, Worrall S, Perea J, Siegel R, Lee J, Molmenti C, Sears CL, Buckhaults P, Hayes R, Hussan H, de Miranda N, Palles C, Diaz L, Song M, Cercek A, Lieu CH, Patel SG, Karlitz JJ, Cao Y, Demb J, Blatchford P, Risendal B, Staples ES, Wali A, Daschner P, Loomans-Kropp H, Flores R, Levell CL, Wehling K, Martin J, Pesmen C, Kuchar V, Soisson R, Davis A, Ahnen D. A Summary of the Fight Colorectal Cancer Working Meeting: Exploring Risk Factors and Etiology of Sporadic Early-Age Onset Colorectal Cancer. Gastroenterology. 2019 08; 157(2):280-288.
    View in: PubMed
    Score: 0.011
  21. Montminy EM, Karlitz JJ, Landreneau SW. Progress of colorectal cancer screening in United States: Past achievements and future challenges. Prev Med. 2019 03; 120:78-84.
    View in: PubMed
    Score: 0.010
  22. Charlton ME, Karlitz JJ, Schlichting JA, Chen VW, Lynch CF. Factors Associated With Guideline-recommended KRAS Testing in Colorectal Cancer Patients: A Population-based Study. Am J Clin Oncol. 2017 Oct; 40(5):498-506.
    View in: PubMed
    Score: 0.010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)